Clinical Trial

Safety of CRIS100 on Treatment Spinal Cord Injury

Not Yet Recruiting Early Phase 1
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to test CRIS100 treatment in participants with acute thoracic spinal cord injury. The main questions it aims to answer are: * safety of CRIS100 * efficacy of CRIS100 Participants will receive 100 mcg CRIS100 in the epicenter of the spinal injury, within 72 hours of the trauma.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-02-13.
Trial Details
NCT Number NCT05739734
Lead Sponsor Cristália Produtos Químicos Farmacêuticos Ltda.
Conditions Thoracic Spinal Cord Injury
Enrollment 5 participants
Start Date 2026-04
Primary Completion 2027-05 (estimated)
Study Completion 2027-05 (estimated)
Updated on ClinicalTrials.gov 2026-02-03